No abstract available
Keywords:
Burkitt lymphoma; bezafibrate; efficacy; medroxyprogesterone; toxicity.
Publication types
-
Clinical Trial, Phase II
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bezafibrate / administration & dosage
-
Burkitt Lymphoma / drug therapy*
-
Burkitt Lymphoma / epidemiology
-
Burkitt Lymphoma / pathology
-
Child
-
Child, Preschool
-
Drug Resistance, Neoplasm
-
Endemic Diseases
-
Female
-
Humans
-
Malawi / epidemiology
-
Male
-
Medroxyprogesterone Acetate / administration & dosage
-
Recurrence
Substances
-
Medroxyprogesterone Acetate
-
Bezafibrate